Skip to main content

Strategy for the Identification of Host-Defense Peptides in Frog Skin Secretions with Therapeutic Potential as Antidiabetic Agents

  • Protocol
  • First Online:
Peptidomics

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2758))

  • 301 Accesses

Abstract

Several amphibian peptides that were first identified on the basis of their antimicrobial or cytotoxic properties have subsequently shown potential for development into agents for the treatment of patients with Type 2 diabetes. A strategy is presented for the isolation and characterization of such peptides that are present in norepinephrine-stimulated skin secretions from a range of frog species. The methodology involves (1) fractionation of the secretions by reversed-phase HPLC, (2) identification of fractions containing components that stimulate the rate of release of insulin from BRIN-BD11 clonal β-cells without simultaneously stimulating the release of lactate dehydrogenase, (3) identification of active peptides in the fractions in the mass range 1–6 kDa by MALDI-ToF mass spectrometry, (4) purification of the peptides to near homogeneity by further reversed-phase HPLC on various column matrices, and (5) structural characterization by automated Edman degradation. The effect of synthetic replicates of the active peptides on glucose homeostasis in vivo may be evaluated in appropriate animal models of Type 2 diabetes such as db/db mice and mice fed a high fat diet to produce obesity, glucose intolerance, and insulin resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bailey CJ, Flatt PR, Conlon JM (2023) An update on peptide-based therapies for type 2 diabetes and obesity. Peptides 161:170939. https://doi.org/10.1016/j.peptides.2023.170939

    Article  CAS  PubMed  Google Scholar 

  2. Xu X, Lai R (2015) The chemistry and biological activities of peptides from amphibian skin secretions. Chem Rev 115:1760–1846. https://doi.org/10.1021/cr4006704

    Article  CAS  PubMed  Google Scholar 

  3. Conlon JM, Mechkarska M, Abdel-Wahab YH, Flatt PR (2018) Peptides from frog skin with potential for development into agents for type 2 diabetes therapy. Peptides 100:275–281. https://doi.org/10.1016/j.peptides.2017.09.001

    Article  CAS  PubMed  Google Scholar 

  4. Conlon JM, Mechkarska M, Leprince J (2019) Peptidomic analysis in the discovery of therapeutically valuable peptides in amphibian skin secretions. Expert Rev Proteomics 16:897–908. https://doi.org/10.1080/14789450.2019.1693894

    Article  CAS  PubMed  Google Scholar 

  5. McClenaghan NH, Barnett CR, Ah-Sing E, Abdel-Wahab YHA, O’Harte FP, Yoon TW, Swanston-Flatt SK, Flatt PR (1996) Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion. Diabetes 45:1132–1140. https://doi.org/10.2337/diab.45.8.1132

    Article  CAS  PubMed  Google Scholar 

  6. Rowlands J, Walz N, Rowles JE, Keane KN, Carlessi R, Newsholme P (2019) Method protocols for metabolic and functional analysis of the BRIN-BD11 β-cell line: a preclinical model for type 2 diabetes. Methods Mol Biol 1916:329–340. https://doi.org/10.1007/978-1-4939-8994-2_32

    Article  CAS  PubMed  Google Scholar 

  7. Owolabi BO, Musale V, Ojo OO, Moffett RC, McGahon MK, Curtis TM, Conlon JM, Flatt PR, Abdel-Wahab YHA (2017) Actions of PGLa-AM1 and its [A14K] and [A20K] analogues and their therapeutic potential as anti-diabetic agents. Biochimie 138:1–12. https://doi.org/10.1016/j.biochi.2017.04.004

    Article  CAS  PubMed  Google Scholar 

  8. McLaughlin CM, Lampis S, Mechkarska M, Coquet L, Jouenne T, King JD, Mangoni ML, Lukic ML, Scorciapino MA, Conlon JM (2016) Purification, conformational analysis, and properties of a family of tigerinin peptides from skin secretions of the crowned bullfrog Hoplobatrachus occipitalis. J Nat Prod 79:2350–2356. https://doi.org/10.1021/acs.jnatprod.6b00494

    Article  CAS  PubMed  Google Scholar 

  9. Musale V, Guilhaudis L, Abdel-Wahab YHA, Flatt PR, Conlon JM (2019) Insulinotropic activity of the host-defense peptide frenatin 2D: conformational, structure-function and mechanistic studies. Biochimie 156:12–21. https://doi.org/10.1016/j.biochi.2018.09.008

    Article  CAS  PubMed  Google Scholar 

  10. Owolabi BO, Ojo OO, Srinivasan DK, Conlon JM, Flatt PR, Abdel-Wahab YH (2016) In vitro and in vivo insulinotropic properties of the multifunctional frog skin peptide hymenochirin-1B: a structure-activity study. Amino Acids 48:535–547. https://doi.org/10.1007/s00726-015-2107-x

    Article  CAS  PubMed  Google Scholar 

  11. Vasu S, Ojo OO, Moffett RC, Conlon JM, Flatt PR, Abdel-Wahab YHA (2017) Anti-diabetic actions of esculentin-2CHa(1-30) and its stable analogues in a diet-induced model of obesity-diabetes. Amino Acids 49:1705–1717. https://doi.org/10.1007/s00726-017-2469-3

    Article  CAS  PubMed  Google Scholar 

  12. Ojo OO, Srinivasan DK, Owolabi BO, McGahon MK, Moffett RC, Curtis TM, Conlon JM, Flatt PR, Abdel-Wahab YH (2016) Molecular mechanisms mediating the beneficial metabolic effects of [Arg4]tigerinin-1R in mice with diet-induced obesity and insulin resistance. Biol Chem 397:753–764. https://doi.org/10.1515/hsz-2016-0120

    Article  CAS  PubMed  Google Scholar 

  13. Musale V, Moffett RC, Owolabi B, Conlon JM, Flatt PR, Abdel-Wahab YHA (2021) Mechanisms of action of the antidiabetic peptide [S4K]CPF-AM1 in db/db mice. J Mol Endocrinol 66:115–128. https://doi.org/10.1530/JME-20-0152

    Article  CAS  PubMed  Google Scholar 

  14. Heydemann A (2016) An overview of murine high fat diet as a model for type 2 diabetes mellitus. J Diabetes Res 2016:2902351. https://doi.org/10.1155/2016/2902351

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Do OH, Low JT, Gaisano HY, Thorn P (2014) The secretory deficit in islets from db/db mice is mainly due to a loss of responding beta cells. Diabetologia 57:1400–1409. https://doi.org/10.1007/s00125-014-3226-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Musale V, Moffett RC, Conlon JM, Flatt PR, Abdel-Wahab YH (2021) Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: a mechanistic study. Peptides 136:170472. https://doi.org/10.1016/j.peptides.2020.170472

    Article  CAS  PubMed  Google Scholar 

  17. Conlon JM, Sonnevend A (2010) Antimicrobial peptides in frog skin secretions. Methods Mol Biol 618:3–14. https://doi.org/10.1007/978-1-60761-594-1_1

    Article  CAS  PubMed  Google Scholar 

  18. Conlon JM, Leprince J (2010) Identification and analysis of bioactive peptides in amphibian skin secretions. Methods Mol Biol 615:145–157. https://doi.org/10.1007/978-1-60761-535-4_12

    Article  CAS  PubMed  Google Scholar 

  19. Conlon JM, Musale V, Attoub S, Mangoni ML, Leprince J, Coquet L, Jouenne T, Abdel-Wahab YHA, Flatt PR, Rinaldi AC (2017) Cytotoxic peptides with insulin-releasing activities from skin secretions of the Italian stream frog Rana italica (Ranidae). J Pept Sci 23:769–776. https://doi.org/10.1002/psc.3025

    Article  CAS  PubMed  Google Scholar 

  20. Frost DR (2023) Amphibian species of the world: an online reference. Version 6.1 electronic database accessible at http://research.amnh.org/herpetology/amphibia/index.html. American Museum of Natural History, New York https://doi.org/10.5531/db.vz.0001. Accessed January 2023

  21. Green AD, Vasu S, Flatt PR (2018) Cellular models for beta-cell function and diabetes gene therapy. Acta Physiol (Oxf) 222(3). https://doi.org/10.1111/apha.13012

  22. Flatt PR, Bailey CJ (1981) Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia 20:573–577. https://doi.org/10.1007/bf00252768

    Article  CAS  PubMed  Google Scholar 

  23. Conlon JM (2007) Purification of naturally occurring peptides by reversed-phase HPLC. Nat Protoc 2:191–197. https://doi.org/10.1038/nprot.2006.437

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Michael Conlon .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Conlon, J.M., Moffett, R.C., Flatt, P.R., Leprince, J. (2024). Strategy for the Identification of Host-Defense Peptides in Frog Skin Secretions with Therapeutic Potential as Antidiabetic Agents. In: Schrader, M., Fricker, L.D. (eds) Peptidomics. Methods in Molecular Biology, vol 2758. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3646-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-3646-6_15

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-3645-9

  • Online ISBN: 978-1-0716-3646-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics